IP Library Granted Patent US 9,968,561
Granted Patent B2
US 9,968,561 · App. 14/776,325 · Granted May 15, 2018

Silk-based capsules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,968,561
App. No.
14/776,325
Granted
May 15, 2018
Kind
B2
Abstract

A hard or soft capsule is disclosed comprising a shell and a fill material, wherein the shell comprises an interpenetrating network comprising a silk polymer and a film-forming natural polymer. A method of making a hard or soft capsule is also disclosed, comprising dissolving a silk protein in a solvent system to form a solubilized silk protein solution; mixing the solubilized silk protein solution with a film-forming natural polymer to form a homogenous shell material; and encapsulating a fill material with the homogenous shell material.

Claims (6)

1. A soft capsule comprising a capsule shell and a fill material, wherein the capsule shell consists essentially of 0.28% of silk fibroin by weight of the capsule shell; 41.8% of gelatin by weight of the capsule shell; 9.5% of glycerol by weight of the capsule shell; 11.4% of sorbitol by weight of the capsule shell; and 37.0% of water by weight of the capsule shell; and wherein the soft capsule provides extended release of the fill material at pH 7.2.

2. The soft capsule of claim 1 , wherein the silk fibroin comprises an average molecular weight ranging from 50 kDa to 450 kDa.

3. The soft capsule of claim 1 , wherein the fill material comprises one or more pharmaceutical agents.

4. The soft capsule of claim 1 , wherein the fill material comprises one or more pharmaceutically acceptable excipients.

5. The soft capsule of claim 1 , wherein the silk fibroin comprise Bombyx mori silk fibroin.

6. The soft capsule of claim 1 , wherein the silk fibroin has a molecular weight of 100 kDa.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Feb 1, 2021
From: MIDCAP FINANCIAL TRUST
To: BIONPHARMA HEALTHCARE LLC; BIONPHARMA HEALTH INC.; BIONPHARMA INC.
Reel/Frame 055100/0105 →
RELEASE OF SECURITY INTEREST Recorded Dec 8, 2020
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP
To: BIONPHARMA INC.; BIONPHARMA HEALTHCARE LLC
Reel/Frame 054575/0365 →
SECURITY INTEREST (TERM) Recorded Oct 9, 2020
From: BIONPHARMA HEALTHCARE LLC (AS LICENSEE FROM PATHEON SOFTGELS INC)
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 054036/0121 →
AMENDED AND RESTATED SECURITY INTEREST (REVOLVING) Recorded Oct 9, 2020
From: BIONPHARMA HEALTHCARE LLC (AS LICENSEE FROM PATHEON SOFTGELS INC)
To: MIDCAP FUNDING IV TRUST, AS AGENT
Reel/Frame 054036/0260 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
SECURITY INTEREST Recorded Jan 4, 2016
From: BIONPHARMA INC.; BIONPHARMA HEALTHCARE LLC
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP
Reel/Frame 037399/0659 →
SECURITY INTEREST (REVOLVER) Recorded Dec 4, 2015
From: BIONPHARMA HEALTHCARE LLC (AS LICENSEE FROM BANNER LIFE SCIENCES, LLC)
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037211/0968 →
SECURITY INTEREST (TERM) Recorded Dec 4, 2015
From: BIONPHARMA HEALTHCARE LLC (AS LICENSEE FROM BANNER LIFE SCIENCES, LLC)
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037212/0135 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2015
From: DYAKONOV, TATYANA; BUSH, DEREK; GOSANGARI, SAUJANYA; YANG, CHUE HUE; MAJURU, SHINGAI; FATMI, AQEEL
To: BANNER LIFE SCIENCES
Reel/Frame 036608/0654 →